ACT and ACQ results, rated asthma control on a 5-point Likert scale (not completely controlled to completely controlled) based on history, physical examination, FEV 1 scores, and National Asthma Education and Prevention Program-defined goals for asthma control. Reliability, validity, and responsiveness were all tested via comparison of the ACT results to the specialists' evaluation, the ACQ scores, and the FEV 1 scores.
RESULTS. Participants (N ϭ 313) had a mean age of 35 years (12-84 years). At baseline, specialists rated asthma control as well controlled or completely controlled (48%), somewhat controlled (29%), and not controlled (23%). The reliability of the ACT was tested by internal consistency and test-retest methods. The internal consistency was .85 for the initial visit (n ϭ 313) and .79 for the follow-up visit (n ϭ 248). The test-retest assessment among 86 patients with the same specialist rating for asthma was .77. The criterion validity was based on comparisons between the ACT scores at the baseline visit and the specialists' assessment as well as the ACQ scores and FEV 1 values. All of these comparisons were found to be statistically significant. The discriminant validity was measured in 3 ways: the asthma specialists' rating, percent predicted value of FEV 1 , and treatment recommendation of the asthma specialists. As predicted, patients with low ACT scores correlated with diagnoses of poorer control by asthma specialists. Patients with low FEV 1 scores also scored lower on the ACT, and patients who required an increase in their therapy had lower scores on this questionnaire. The responsiveness of the ACT was also measured by assessing the changes in scores between the initial and follow-up visits. Moderate correlations existed between the ACT and the asthma specialist's score, whereas changes in the ACT and ACQ were found to be highly consistent. Changes in FEV 1 and ACT were only minimally correlated. An ACT score of Յ19 identified patients with poorly controlled asthma (71% sensitivity; 71% specificity).
CONCLUSIONS. The ACT was reliable, valid, and responsive to changes in asthma control over time in a sample of patients who were new to the care of an asthma specialist.
REVIEWER COMMENTS. These authors have further shown the value of the ACT in assessing asthma control in the practice of asthma specialists. In a day when physicians are pressed for time when evaluating patients, it is important to find effective tools that are reliable, valid, responsive, and practical to assist in patient evaluations. Additional work is needed to assess the usefulness of the ACT within primary care, where it may prove to be even more valuable in assessing asthma control. STUDY POPULATION. Participants were US children (aged 4 to 18 years) with current asthma during February to May, 2004, identified in a telephone-based survey. Asthma was defined as ever having a physician diagnosis of asthma and either using current asthma medication or having asthma symptoms in the past year.
METHODS. In this telephone-based study, 41 433 households were screened to provide 1089 children reporting current asthma and 801 completed interviews. Interviews were completed by parents for children 4 to 15 years old (84.6%) and the children themselves when they were 16 to 18 years old (14.6%). Symptoms, perceived level of control, activity limitation, health care use, medications, disease management, and knowledge were assessed. Global asthma-symptom burden was composed of short-term symptom burden (4-week recall), long-term symptom burden (past year), and functional impact (activity limitation) based on National Asthma Education and Prevention Program (NAEPP) guidelines. Asthma was classified on the basis of symptoms in 3 categories: mild-intermittent, mild-persistent, and moderate/severe-persistent (combined into 1 category) asthma.
RESULTS. Eighty percent of the children were classified as having mild-intermittent asthma on the basis of daily symptoms; however, this percentage decreased to 64% when nighttime symptoms were considered. In contrast, on the basis of the global asthma-symptom burden, only 13% of the children were classified as having mildintermittent disease, whereas 62% were classified as having moderate/severe disease. Of children with moderate/severe asthma, 54% reported complete asthma control despite meeting criteria for more moderate/ severe-persistent disease. Asthma impact on daily activity was substantial, with 47% of the children avoiding exertion and 34% staying inside to control asthma symptoms.
CONCLUSIONS. The majority of children had not achieved the goals of asthma treatment based on NAEPP guidelines. In addition, parents and their children overestimated the child's asthma control and commonly restricted activities to control asthma symptoms. 1998 -2001) . On the basis of the age range of the available reference for pulmonary-function values, analyses were restricted to children aged 8 to 11 years.
METHODS. Data collected from both studies included a comprehensive history, allergy skin testing, and pulmonaryfunction tests. Each child's asthma severity was classified according to the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 2 guideline on the basis of their symptom frequency alone. Participants were classified into 3 severity levels: mild-intermittent, mild-persistent, and moderate-to-severe-persistent asthma. Then, those participants with abnormal results of the pulmonary-function test (forced expiratory volume in 1 second [FEV 1 ] and/or peak expiratory flow [PEF] rate) were reclassified on the basis of symptom-frequency data plus pulmonary-function results.
RESULTS. Among children with symptoms consistent with mild-intermittent asthma, 22.8% in cohort 1 and 27.7% in cohort 2 would be reclassified as having moderate-tosevere-persistent asthma. Among children with symptoms consistent with mild-persistent asthma, 31.2% in cohort 1 and 33.3% in cohort 2 would be reclassified as having moderate-to-severe-persistent asthma. Among children who were already classified as having moderate-to-severe-persistent asthma according to their symptoms alone, 22.3% in cohort 1 and 44.2% in cohort 2 had abnormal pulmonary function.
CONCLUSIONS. Approximately one third of the children in each cohort were reclassified to higher NAEPP asthmaseverity categories when pulmonary function was considered in addition to symptom frequency. The results demonstrate that the current NAEPP severity-assessment algorithm is highly dependent on the availability of symptom-frequency and pulmonary-function data.
REVIEWER COMMENTS. Successful management of asthma requires both accurate determination of asthma severity and proper treatment. Unfortunately, studies have shown that health care providers often underestimate asthma severity. The NAEPP guidelines recommend the use of both symptom frequency and pulmonary function (PEF and FEV 1 ) in assessing asthma severity. A peak flow meter is a relatively simple, inexpensive device; however, it is effort dependent and may not detect those patients with air trapping, because they may still be able to produce a peak burst, resulting in a normal PEF, although they have abnormal FEV 1 . Even with their limitations, pulmonary-function tests along with symptom frequency can be helpful in achieving a more accurate assessment of asthma severity, as was demonstrated in this study. As we continue to strive toward better asthma care, the NAEPP Expert Panel Report 3 plans to continue to emphasize assessment of severity and management as well as focus on asthma control. To measure and compare exhaled nitric oxide (eNO) levels in patients with asthma and healthy volunteers, to study peripheral blood lymphocyte cytokine expression, and to study the relationship between eNO and intracellular cytokine expression.
STUDY POPULATION. A total of 36 subjects were enrolled onto the study, with 19 asthmatic patients and 17 healthy control subjects.
METHODS. At least once per week for 4 weeks, patients with asthma visited the clinic and underwent a detailed history, physical examination, spirometry, and eNOlevel measurement. These patients were maintained on established pharmacologic therapy regimens. A blood
